Jane Gross

Direktor/Vorstandsmitglied bei ATYR PHARMA, INC.

Vermögen: 9 570 $ am 30.04.2024

67 Jahre

Health Technology

Consumer Services

Aktive Positionen von Jane Gross

Unternehmen	Position	Beginn	Ende
ATYR PHARMA, INC.	Direktor/Vorstandsmitglied	28.06.2019	-
ATYR PHARMA, INC.	Independent Dir/Board Member	28.06.2019	-
BRIACELL THERAPEUTICS CORP.	Direktor/Vorstandsmitglied	01.11.2021	-
BRIACELL THERAPEUTICS CORP.	Independent Dir/Board Member	01.11.2021	-
Washington Biotechnology & Biomedical Association	Direktor/Vorstandsmitglied	-	-
BriaPro Therapeutics Corp. BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada.	Direktor/Vorstandsmitglied	-	-
	Independent Dir/Board Member	-	-

Unternehmen	Position	Beginn	Ende
APTEVO THERAPEUTICS INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2016	14.09.2021
EMERGENT BIOSOLUTIONS INC.	Corporate Officer/Principal	01.07.2011	01.08.2016
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Corporate Officer/Principal	01.02.2009	01.06.2010

University of California, Berkeley

Doctorate Degree

International

Vereinigte Staaten	7
Kanada	3

Operativ

Director/Board Member	4
Independent Dir/Board Member	3
Corporate Officer/Principal	2

Sektoral

Health Technology	7
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
APTEVO THERAPEUTICS INC.	Health Technology
ATYR PHARMA, INC.	Health Technology
EMERGENT BIOSOLUTIONS INC.	Health Technology
BRIACELL THERAPEUTICS CORP.	Health Technology

Private Unternehmen	3
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology
Washington Biotechnology & Biomedical Association
BriaPro Therapeutics Corp. BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada.	Health Technology